If you ever want to get mad about capitalism, remind yourself that most drugs that cost >$10,000 a month to take are trivially inexpensive to manufacture and can usually still be massively profitable at a fraction of the cost
In 2015, the 15 companies listed appear to have accounted for roughly half of global expenditure on pharmaceutical R&D. So these 20 drugs would only just about cover the total global expenditure on R&D that year (very crudely)
-
-
1) cite rather than illegible screen shot from who knows what. 2) What's the ROI? Happy to argue if you actual data.
-
The total expenditure figure is from Statista, so might be a bit of an underestimate: https://www.statista.com/statistics/309466/global-r-and-d-expenditure-for-pharmaceuticals/ … ROI is, according to the article I cited, ~15-25% which is pretty impressive
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.